MoneyWorks4Me

Neuland Laboratories - Quaterly Results

11 May 2023 Evaluate
A decent increase of about 59.09% in the turnover to Rs. 4070.73 millions was observed for the quarter ended March 2023. The turnover stood at Rs. 2558.73 millions during the similar quarter previous year.The Net Profit of the company vaulted to 287.18% to Rs. 845.10  millions from Rs. 218.27 millions in the previous quarter.Operating Profit saw a handsome growth to 1277.81 millions from 393.44 millions in the quarter ended March 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 4070.73 2558.73 59.09 11911.98 9510.77 25.25 11911.98 9510.77 25.25
Other Income 80.64 6.31 1177.97 97.48 20.77 369.33 97.48 20.77 369.33
PBIDT 1277.81 393.44 224.78 2810.56 1442.71 94.81 2810.56 1442.71 94.81
Interest 42.89 27.70 54.84 130.67 134.94 -3.16 130.67 134.94 -3.16
PBDT 1234.92 365.74 237.65 2679.89 1307.77 104.92 2679.89 1307.77 104.92
Depreciation 134.70 124.52 8.18 527.76 490.36 7.63 527.76 490.36 7.63
PBT 1100.22 241.22 356.11 2152.13 817.41 163.29 2152.13 817.41 163.29
TAX 255.12 22.95 1011.63 520.94 182.06 186.14 520.94 182.06 186.14
Deferred Tax 1.76 -47.35 -103.72 17.04 -22.16 -176.90 17.04 -22.16 -176.90
PAT 845.10 218.27 287.18 1631.19 635.35 156.74 1631.19 635.35 156.74
Equity 129.01 129.01 0.00 129.01 129.01 0.00 129.01 129.01 0.00
PBIDTM(%) 31.39 15.38 104.15 23.59 15.17 55.54 23.59 15.17 55.54
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..